Catharine I. Paules

Infectious Disease

500 University Dr
Hershey, PA 17033

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Transplant Infectious Diseases Work Standards-Results From a Mid-Atlantic Regional Survey.

Transplant Infectious Diseases Work Standards-Results From a Mid-Atlantic Regional Survey.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: January 12, 2026

Analyzing Real-World Infection Risk in Multiple Myeloma Patients Receiving Teclistamab.

Analyzing Real-World Infection Risk in Multiple Myeloma Patients Receiving Teclistamab.

Journal: Current oncology (Toronto, Ont.)

Published: January 10, 2026

Vaccine Effectiveness Among 5- to 17-year-old Individuals with Prior SARS-CoV-2 Infection: An EHR-Based Target Trial Emulation Study from the RECOVER Project.

Vaccine Effectiveness Among 5- to 17-year-old Individuals with Prior SARS-CoV-2 Infection: An EHR-Based Target Trial Emulation Study from the RECOVER Project.

Journal: Research square

Published: July 09, 2025

Target Trial Emulation of Vaccine Effectiveness in 5- to 17-years-olds with Prior SARS-CoV-2 Infection.

Target Trial Emulation of Vaccine Effectiveness in 5- to 17-years-olds with Prior SARS-CoV-2 Infection.

Journal: Nature communications

Published: June 21, 2025

Respiratory and Other Infections Following COVID.

Respiratory and Other Infections Following COVID.

Journal: Pediatrics

Published: March 05, 2025

Vaccine Effectiveness Among 5- to 17-year-old Individuals with Prior SARS-CoV-2 Infection: An EHR-Based Target Trial Emulation Study from the RECOVER Project.

Vaccine Effectiveness Among 5- to 17-year-old Individuals with Prior SARS-CoV-2 Infection: An EHR-Based Target Trial Emulation Study from the RECOVER Project.

Journal: medRxiv : the preprint server for health sciences

Published: February 20, 2025

Dose-dependent impact of tixagevimab-cilgavimab as primary prevention against SARS-CoV-2 in immunocompromised individuals.

Dose-dependent impact of tixagevimab-cilgavimab as primary prevention against SARS-CoV-2 in immunocompromised individuals.

Journal: Scientific reports

Published: January 27, 2025

Rates of Sudden Unexpected Infant Death Before and During the COVID-19 Pandemic.

Rates of Sudden Unexpected Infant Death Before and During the COVID-19 Pandemic.

Journal: JAMA network open

Published: September 26, 2024

Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19.

Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19.

Journal: BMC infectious diseases

Published: September 05, 2024

Maternal stress and fetoplacental cortisol regulation in small-for-gestational-age newborns.

Maternal stress and fetoplacental cortisol regulation in small-for-gestational-age newborns.

Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology

Published: August 04, 2024

A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2.

A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2.

Journal: Annals of internal medicine

Published: February 26, 2024

Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation.

Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation.

Journal: Leukemia research

Published: February 12, 2024

Showing 1-12 of 57

Last Updated: 09/26/2026